Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Martina Fabris and Carlo Tascini.
Martina Fabris
Connection Strength
1.336
Carlo Tascini
  1. The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery. J Clin Microbiol. 2021 10 19; 59(11):e0113821.
    View in: PubMed
    Score: 0.240
  2. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021 Oct; 27(10):1507-1513.
    View in: PubMed
    Score: 0.237
  3. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia. Cytokine. 2021 04; 140:155438.
    View in: PubMed
    Score: 0.231
  4. Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care. J Clin Virol. 2020 08; 129:104444.
    View in: PubMed
    Score: 0.221
  5. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19. Eur J Clin Microbiol Infect Dis. 2021 Dec; 40(12):2597-2604.
    View in: PubMed
    Score: 0.060
  6. CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial. Int Immunopharmacol. 2021 Sep; 98:107874.
    View in: PubMed
    Score: 0.059
  7. Authors' Reply to Cattaneo et al.: "Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6". Clin Pharmacokinet. 2021 06; 60(6):833-834.
    View in: PubMed
    Score: 0.059
  8. MR-proADM as prognostic factor of outcome in COVID-19 patients. Sci Rep. 2021 03 04; 11(1):5121.
    View in: PubMed
    Score: 0.058
  9. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci. 2020 Dec; 41(12):3391-3394.
    View in: PubMed
    Score: 0.057
  10. Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6. Clin Pharmacokinet. 2020 10; 59(10):1251-1260.
    View in: PubMed
    Score: 0.057
  11. Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6. J Med Virol. 2020 11; 92(11):2852-2856.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.